Could a smart monitor improve pregnancy outcomes for women with diabetes?

NCT ID NCT05317585

Recruiting now Disease control Sponsor: University of Massachusetts, Worcester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study compares continuous glucose monitors (CGMs) to standard fingerstick testing in 180 pregnant women with type 2 diabetes. The goal is to see if CGMs reduce the number of large babies and improve blood sugar control. Participants will use either a CGM or traditional fingerstick checks throughout pregnancy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous Glucose Monitor (device)
What this could lead to: If successful, this could show that using a continuous glucose monitor helps pregnant women with type 2 diabetes have healthier babies and better blood sugar control.
What could go wrong: This is a relatively small trial (180 participants) and results may not apply to all pregnant women. The device itself is low-risk, but improved outcomes are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY, HIGH RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREGNANCY, HIGH RISK TYPE 2 DIABETES TREATED WITH INSULIN

Contacts and locations

Locations

University of Massachusetts Memorial Medical Center
RECRUITING

Worcester, Massachusetts, 01605, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.